XNYSCNC
Market cap30bUSD
Dec 26, Last price
60.91USD
1D
0.13%
1Q
-18.33%
Jan 2017
115.61%
Name
Centene Corp
Chart & Performance
Profile
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 153,999,000 6.54% | 144,547,000 14.74% | 125,982,000 13.38% | |||||||
Cost of revenue | 122,458,000 | 127,891,000 | 121,949,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 31,541,000 | 16,656,000 | 4,033,000 | |||||||
NOPBT Margin | 20.48% | 11.52% | 3.20% | |||||||
Operating Taxes | 899,000 | 760,000 | 477,000 | |||||||
Tax Rate | 2.85% | 4.56% | 11.83% | |||||||
NOPAT | 30,642,000 | 15,896,000 | 3,556,000 | |||||||
Net income | 2,702,000 124.79% | 1,202,000 -10.76% | 1,347,000 -25.50% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (1,589,000) | (3,026,000) | (262,000) | |||||||
BB yield | 3.92% | 6.34% | 0.54% | |||||||
Debt | ||||||||||
Debt current | 287,000 | 82,000 | 267,000 | |||||||
Long-term debt | 19,638,000 | 21,251,000 | 22,190,000 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 2,738,000 | 5,616,000 | 5,610,000 | |||||||
Net debt | (16,013,000) | (7,746,000) | (6,243,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 8,053,000 | 6,261,000 | 4,205,000 | |||||||
CAPEX | (799,000) | (1,004,000) | (910,000) | |||||||
Cash from investing activities | (1,191,000) | (2,921,000) | (3,299,000) | |||||||
Cash from financing activities | (1,658,000) | (4,197,000) | 1,362,000 | |||||||
FCF | 30,659,000 | 16,855,000 | 2,939,000 | |||||||
Balance | ||||||||||
Cash | 19,652,000 | 14,395,000 | 14,657,000 | |||||||
Long term investments | 16,286,000 | 14,684,000 | 14,043,000 | |||||||
Excess cash | 28,238,050 | 21,851,650 | 22,400,900 | |||||||
Stockholders' equity | 11,508,000 | 8,390,000 | 8,444,000 | |||||||
Invested Capital | 36,231,000 | 39,483,000 | 43,026,000 | |||||||
ROIC | 80.94% | 38.53% | 8.74% | |||||||
ROCE | 65.19% | 34.35% | 7.63% | |||||||
EV | ||||||||||
Common stock shares outstanding | 545,704 | 582,040 | 590,516 | |||||||
Price | 74.21 -9.51% | 82.01 -0.47% | 82.40 37.26% | |||||||
Market cap | 40,496,694 -15.16% | 47,733,100 -1.90% | 48,658,518 39.96% | |||||||
EV | 24,599,694 | 40,167,100 | 42,642,518 | |||||||
EBITDA | 32,834,000 | 18,209,000 | 5,509,000 | |||||||
EV/EBITDA | 0.75 | 2.21 | 7.74 | |||||||
Interest | 725,000 | 665,000 | 665,000 | |||||||
Interest/NOPBT | 2.30% | 3.99% | 16.49% |